Apellis Pharmaceuticals, Inc.
(NASDAQ : APLS)

( )
APLS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
MRKMerck & Co., Inc. -1.21%81.340.7%$984.93m
PFEPfizer Inc. -2.91%34.680.9%$941.81m
ABBVAbbVie, Inc. -1.94%93.122.3%$934.45m
JNJJohnson & Johnson -2.01%145.990.7%$926.74m
BMYBristol-Myers Squibb Co. -2.55%63.961.0%$765.27m
LLYEli Lilly & Co. -2.73%138.161.1%$477.06m
NVSNovartis AG -6.92%90.060.2%$174.74m
GSKGlaxoSmithKline Plc -2.69%41.920.2%$163.07m
AZNAstraZeneca Plc -5.14%47.591.2%$150.12m
BHCBausch Health Cos., Inc. -1.85%26.010.0%$96.00m
RETAReata Pharmaceuticals, Inc. -7.06%196.233.4%$87.55m
SNYSanofi -1.99%49.840.2%$82.42m
GNPXGenprex, Inc. 13.13%6.030.0%$80.63m
NVONovo Nordisk A/S -3.99%61.310.1%$76.21m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -1.76%44.540.0%$55.85m

Company Profile

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Crestwood, KY.